Biosimilar medicines in rheumatologySubscription
The long-term safety of biosimilar medicines is unknown, but while their use in rheumatology practice is supported, switching patients currently responding and tolerating the reference product is not.
A wide range of drug classes are used to treat osteoarthritis, although there is a lack of detailed guidance because of the variable nature of the condition.
Rheumatoid arthritis: a patient’s journeySubscription
This case study aims to help you understand the diagnosis of rheumatoid arthritis, the different medicines that may be prescribed and the support you can give patients
Rheumatoid arthritis: a patient’s journey (II)Subscription
Acute management and prevention of goutSubscription
Osteoarthritis: pathophysiology and diagnosisSubscription